메뉴 건너뛰기




Volumn 141, Issue 1, 2016, Pages 140-147

Performance of AGO score for secondary cytoreduction in a high-volume U.S. center

Author keywords

Recurrent ovarian cancer; Secondary cytoreduction

Indexed keywords

AGO SCORE; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CYTOREDUCTIVE SURGERY; DISEASE FREE INTERVAL; FEMALE; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; MINIMAL RESIDUAL DISEASE; OVARY CANCER; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; UNITED STATES; AGED; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE;

EID: 84957084308     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.01.027     Document Type: Article
Times cited : (27)

References (10)
  • 4
    • 84933280557 scopus 로고    scopus 로고
    • External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer
    • R. Van de Laar, L. M, T. Van Gorp, J. IntHout, P.L. Zusterzeel, and F.Y. Kruitwagen External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer Gynecol. Oncol. 137 2015 210 215
    • (2015) Gynecol. Oncol. , vol.137 , pp. 210-215
    • Van De Laar, R.1    Van Gorp, T.2    Inthout, J.3    Zusterzeel, P.L.4    Kruitwagen, F.Y.5
  • 5
    • 84893717802 scopus 로고    scopus 로고
    • Secondary complete cytoreduction in recurrent ovarian cancer: Benefit of optimal patient selection using scoring system
    • E. Laas, M. L, M. De Cuypere, F. Selle, E. Darai, D. Querleu, R. Rouzier, and E. Chereau Secondary complete cytoreduction in recurrent ovarian cancer: benefit of optimal patient selection using scoring system Int. J. Gynecol. Cancer 24 2014 238 246
    • (2014) Int. J. Gynecol. Cancer , vol.24 , pp. 238-246
    • Laas, E.1    De Cuypere, M.2    Selle, F.3    Darai, E.4    Querleu, D.5    Rouzier, R.6    Chereau, E.7
  • 6
    • 84896395212 scopus 로고    scopus 로고
    • Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer
    • P. Harter, B. Bbb, P.F. Alesina, D. Lorenz, A. Boergers, F. Heitz, R. Hils, C. Kurzeder, A. Traut, and A. du Bois Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer Gynecol. Oncol. 132 2014 537 541
    • (2014) Gynecol. Oncol. , vol.132 , pp. 537-541
    • Harter, P.1    Bbb, B.2    Alesina, P.F.3    Lorenz, D.4    Boergers, A.5    Heitz, F.6    Hils, R.7    Kurzeder, C.8    Traut, A.9    Du Bois, A.10
  • 10
    • 84947126332 scopus 로고    scopus 로고
    • A predictive score for secondary cytoreductive surgery in recurrent ovarian cancer (SeC-Score): A single-centre, controlled study for preoperative patient selection
    • R. Angioli, S. C, A. Aloisi, R. Ricciardi, G. Scaletta, S. Lopez, A. Miranda, A. Di Pinto, C. Terranova, and F. Plotti A predictive score for secondary cytoreductive surgery in recurrent ovarian cancer (SeC-Score): a single-centre, controlled study for preoperative patient selection Ann. Surg. Oncol. 2015
    • (2015) Ann. Surg. Oncol.
    • Angioli, R.1    Aloisi, A.2    Ricciardi, R.3    Scaletta, G.4    Lopez, S.5    Miranda, A.6    Di Pinto, A.7    Terranova, C.8    Plotti, F.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.